When selecting the reference product, the following conditions must first be followed:
1. First of all, the reference medicinal product should be a medicinal product that is an original medicinal product with proven efficacy, safety and quality.
2. In the absence of an original medicinal product in the world and/or a proven impossibility of identifying it, the following selection procedure should be followed:
2.1. first of all, a medicinal product recommended by the WHO as a reference medicinal product and information on which is posted on the official WHO website is considered;
2.2. in the absence of a WHO recommendation, a medicinal product that was registered as an innovative one on the basis of evidence of efficacy, safety and quality at the national level in countries whose regulatory authorities apply high quality standards is used as the reference medicinal product;
2.3. In the absence of the original medicinal product and/or proven impossibility of identifying it, and in case of non-compliance with paragraphs 1 and 2, a medicinal product for which the following criteria are met is used as the reference medicinal product:
a) widely documented clinical trials published in scientific journals;
b) a long and problem-free period of post-registration control.